S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
CGC   19.25 (-5.17%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
T   39.17 (-0.51%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
BAC   33.09 (-0.27%)
DIS   138.58 (+1.35%)
S&P 500   3,091.84 (+0.16%)
DOW   27,691.49 (+0.00%)
QQQ   201.54 (+0.29%)
CGC   19.25 (-5.17%)
BABA   186.97 (+0.14%)
GE   11.42 (+0.62%)
T   39.17 (-0.51%)
F   9.04 (-0.44%)
ACB   3.57 (-1.38%)
BAC   33.09 (-0.27%)
DIS   138.58 (+1.35%)
Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space
(ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Portola PharmaceuticalsBiohaven PharmaceuticalAkcea TherapeuticsZogenixCambrex
SymbolNASDAQ:PTLANYSE:BHVNNASDAQ:AKCANASDAQ:ZGNXNYSE:CBM
Price Information
Current Price$27.68$49.02$19.25$44.35$59.85
52 Week RangeBuyBuyBuyBuyHold
Analyst Ratings
Consensus RecommendationBuyBuyBuyBuyHold
Consensus Price Target$40.00$72.00$35.00$59.60$52.40
% Upside from Price Target44.51% upside46.88% upside81.82% upside34.39% upside-12.45% downside
Trade Information
Market Cap$2.21 billion$2.54 billion$1.81 billion$1.92 billion$2.02 billion
Beta2.080.341.541.942.17
Average Volume1,146,367707,470203,964564,118362,887
Sales & Book Value
Annual Revenue$40.13 millionN/A$64.87 million$9.82 million$532.09 million
Price / Sales53.68N/A27.86199.833.79
CashflowN/AN/AN/AN/A$3.91 per share
Price / CashN/AN/AN/AN/A15.32
Book Value$1.36 per share$3.74 per share$3.10 per share$12.46 per share$19.48 per share
Price / Book20.35N/A6.213.563.07
Profitability
Net Income$-350,220,000.00$-240,920,000.00$-225,820,000.00$-123,910,000.00$92.41 million
EPS($5.01)($6.15)($2.74)($3.23)$2.77
Trailing P/E RatioN/AN/AN/AN/A21.61
Forward P/E RatioN/AN/AN/AN/A42.75
P/E GrowthN/AN/AN/AN/A$4.67
Net Margins-275.13%N/A-50.71%N/A5.96%
Return on Equity (ROE)-282.04%-237.81%-33.00%-31.44%5.38%
Return on Assets (ROA)-57.81%-89.87%-27.34%-23.59%2.50%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity Ratio1.25%N/A0.04%0.04%0.76%
Current Ratio5.88%8.96%6.46%3.00%2.37%
Quick Ratio5.85%8.96%6.26%3.00%1.70%
Ownership Information
Institutional Ownership PercentageN/A88.91%25.44%N/AN/A
Insider Ownership Percentage4.50%23.90%4.10%4.40%1.41%
Miscellaneous
Employees32463248901,732
Shares Outstanding77.82 million52.24 million93.90 million44.25 million33.72 million
Next Earnings Date3/6/2020 (Estimated)2/27/2020 (Estimated)2/25/2020 (Estimated)2/27/2020 (Estimated)11/14/2019 (Estimated)
OptionableOptionableOptionableOptionableOptionableOptionable
 Portola PharmaceuticalsBiohaven PharmaceuticalAkcea TherapeuticsZogenixCambrex

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel